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Abstract.  Retina-derived growth factor (RDGF) is a 
polypeptide growth factor purified from salt extracts of 
bovine retinas on the basis of its mitogenic activity for 
capillary endothelial cells (EC) and BALB/c 3T3 cells. 
RDGF is angiogenic in vivo.  We show here that 
RDGF induces neurite extension by PC12 cells and 
that this neurite outgrowth is dramatically potentiated 
by heparin. Neurite formation elicited by RDGF in the 
presence of heparin cannot be distinguished from that 
elicited by nerve growth factor (NGF) either by the 
time course of neurite formation or by the morphology 
of the neurites at the level of the light microscope. 
Neurite outgrowth induced by either purified RDGF or 
by a crude retinal extract is not blocked by antibodies 
to NGE  Furthermore, neurite outgrowth induced by 
NGF is not potentiated by heparin and NGF is not 
mitogenic for capillary EC. Thus, RDGF has profound 
regulatory effects on cell types of very different em- 
bryonic origins. These results indicate that the physio- 
logical role for this growth factor may be far more 
complex than previously suspected and suggest that the 
formation of neural connections and the process of 
vascularization may unexpectedly share common 
regulatory elements. 
ETINA-DERIVED growth factor (RDGF) ~  is an anion- 
ic endothelial cell (EC) mitogen (two forms: molec- 
ular masses of 16,500 and 18,000 D) that has been 
purified from bovine retina by taking advantage of its un- 
usually high affinity for the negatively charged glycosamino- 
glycan heparin (1, 5). Based on its biological and biochemi- 
cal similarities,  RDGF appears to be closely related if not 
identical to anionic growth factors that have been purified 
from other tissues including the hypothalamus and the brain 
(1, 5, 22, 26). Interestingly, the mitogenic activity of RDGF, 
as well as an EC growth  factor from hypothalamus,  have 
been shown to be potentiated by the addition of heparin (28, 
35),  suggesting a role for the interaction of growth factors 
with heparin-like  molecules. 
We have assayed the ability of RDGF to stimulate neurite 
extension by PC12 cells. This cell line, cloned from a trans- 
plantable pheochromocytoma, has been a useful model sys- 
tem for the study of nerve growth factor (NGF) action and 
the molecular  mechanism  of neurite  extension (14). PC12 
cells have surface receptors for NGF (3); and,  in the pres- 
ence of NGF, extend long nervelike processes (neurites), be- 
come electrically excitable, increase the rate of neurotrans- 
mitter synthesis, make synapses with appropriate cell types 
in culture, and assume many of the characteristics of mature 
sympathetic nerves (3, 6, 30-32,  36). 
1. Abbreviations used in this paper:  EC, endothelial cell;  FGF, fibroblast 
growth factor;  NGF,  nerve growth factor;  RDGF,  retina-derived growth 
factor. 
Our results indicate that RDGF can induce neurite forma- 
tion by PC12 cells and that this induction is strongly poten- 
tiated by heparin. These RDGF-induced neurites are similar 
to those induced by NGF both morphologically  and in the 
time course of their formation yet the induction by RDGF 
is not blocked by antisera to NGE These data indicate that 
RDGF may be a member of a new class of potent neuronal 
growth factors. 
Materials and Methods 
PC12 Cells 
The PC12  cells were grown in Dulbecco's modified Eagle's medium with 
10% fetal calf serum (Flow Laboratories, Inc., McLean, VA) and 5% horse 
serum (KC Biological Inc., Lenexa, KS). For the neurite assay, PC12 cells 
were plated  at  5×104 per  well  into 24-well  plates and allowed to attach 
overnight. The test substances were then added, the cells were incubated 
for 62 h,  and the number of cells  with neurites were  determined.  The 
criteria for a neurite was a process with a distinct growth cone, attached to 
the cell body by a narrow, phase-dense process greater than one-half cell 
diameters in length. Processes >ll/z cell diameters long were scored as long 
neurites. 250 cells were scored for each data point.  NGF was purified as 
described elsewhere (27). 
Capillary Endothelial Cells 
Capillary fragments were isolated from bovine adrenal medulla and the EC 
cultured as previously described (9).  The assays measuring the effects of 
RDGF and NGF on the proliferation of subconfluent capillary EC and DNA 
synthesis by BALB/c 313 cells were conducted as described elsewhere (5). 
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RDGF used in most of the reported studies was purified •200,000-fold  by 
the methods of Dg,  more and Klagsbrun (5) and was '~50% pure. Briefly, 
the retinas were extracted for 3 h into Hanks balanced salt solution followed 
by precipitation at pH 4. The acid-soluble material was then applied to a 
Bio-Rex cation exchange (Bio-Rad Laboratories, Richmond, CA) column, 
which bound all  of the  cationic components including basic  fibroblast 
growth factor (FGF) if there was any in the preparation (33).  The flow- 
through of the cation exchange column, containing all of the acidic 3T3 and 
EC stimulatory activity, was then applied to a heparin-Sepharose column 
and the activity was eluted with 0.9-1.1  M NaCI in a 0.1-2.0 M gradient. 
The peak of  activity recovered from this column is the material used through 
these studies except where noted (i.e., Fig.  2).  Final purification of the 
RDGF to >95 % homogeneity was accomplished using a Mono S cation ex- 
change (Pharmacia Fine Chemicals, Piscataway,  N J) or a DEAE anion ex- 
change column (P. D~more, manuscript submitted). The Mono S column 
separates the major 16,500-D  form from a minor 18,000-D form, whereas 
the DEAE column yields the purified doublet. Presumably RDGF binds to 
the Mono S column but not the Bio-Rex used earlier in the purification 
scheme because the former is a stronger cation exchange resin. The RDGF 
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Figure 1. Heparin potentiates the action of RDGF but not NGF on 
neurite  production  by PC12 cells.  PC12 cells were grown in the 
presence or absence of heparin (10 lxg/ml) with increasing concen- 
trations of RDGF (A) or NGF (B) as indicated, and assayed for the 
production  of neurites  62  h  after plating.  The experiments  de- 
scribed in this paper have all been repeated at least three times using 
at  least  two  different  preparations  of RDGF  with  comparable 
results. 
purified by either of these protocols has been shown to be at least 90% free 
of cationic FGF through studies using antisera directed against synthetic 
peptides specific for basic FGF (Sasse, J., and M. Klagsbrun, personal com- 
munication). 
Heparin 
A previous publication by Folkman et al. (10) reported variability in various 
commercial preparations of heparin. The variability observed by these in- 
vestigators concerned the ability of heparin to cause tumor regression when 
administered to animals along with cortisone. We have assayed heparins 
from a number of commercial sources for the ability to potentiate the mito- 
genic response of RDGF on EC and found no significant difference (E A. 
DAmore, unpublished data). We have therefore selected one brand of hepa- 
rin (Hepar Industries, Inc.,  Franklin,  OH),  which is used in all of our 
reported studies. 
Results 
Induction of neurite formation in PC12 cells by a preparation 
of RDGF that contained both high and low molecular weight 
forms of the factor was quantitated both in the presence and 
in the absence of heparin (10 ~tg/ml) (Fig.  1 A). In the pres- 
ence of heparin, neurite outgrowth occurred at very low con- 
centrations of RDGF; the concentration of RDGF required 
to produce half-maximal effect was '~1 ng/ml (60 pM). This 
was slightly less than the concentration of NGF required to 
elicit  neurite  outgrowth  under  identical  conditions  (half- 
maximal at 3 ng/ml; 240 pM), and was comparable to the 
concentration of RDGF required for half-maximal stimula- 
tion of cell division in capillary EC and 3T3 cells (1 ng/ml). 
PC12 cells responded to the addition of RDGF in the absence 
of heparin by extending neurites,  but only at significantly 
higher  concentrations  (100  ng/ml).  Neurite  induction  by 
RDGF in the absence of heparin was not as pronounced as 
the response in the presence of heparin and the effect was not 
saturable  in  this  assay even at the  highest  concentrations 
tested (800 ng/ml) (Fig.  1 A). 
Heparin potentiation of neurite outgrowth was specific for 
RDGF; heparin caused no significant increase in the potency 
of NGF (Fig. 1 B), and heparin alone had no effect on neurite 
formation.  In  fact,  at  saturating  concentrations  of NGE 
heparin decreased the percentage of cells with neurites (Fig. 
1 B). Furthermore, heparin did not increase the potency of 
two agents that are known to stimulate adenylate cyclase in 
PC12  (cholera toxin  and  the  adenosine analogue,  phenyl- 
isopropyladenosine) (7,  17) when neurite extension was as- 
sayed (data not shown). Thus, it appears that heparin is in- 
volved in the interaction between RDGF and the cell, rather 
than having an independent regulatory effect on PC12 cells. 
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Figure 2. Neurite extension is elicited 
by both high and low molecular weight 
forms of RDGE  RDGF was further 
purified on a strong cation exchange 
column  (Mono  S,  Pharmacia  Fine 
Chemicals,  Piscataway,  NJ)  as  de- 
scribed  in  Materials  and  Methods. 
The ability of both forms of RDGF to 
cause neurite extension was measured 
in the presence and absence of heparin 
at 62 h after plating. 
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ng/ml) or to RDGF (10 ng/ml) in the presence of  heparin (10 gg/ml). The medium was changed every second day. Arrowheads,  growth cones. 
The  two forms of RDGF can be separated by a  strong 
cation ion exchange column as described in Materials and 
Methods.  Neurites were induced in PC12  cells by both the 
high and low molecular weight forms of RDGF separated by 
this  additional  fractionation  step,  and  the  action  of both 
forms was potentiated by heparin (Fig.  2).  Both  forms of 
RDGF also exhibited mitogenic activity on EC and 3T3 cells 
(data not  shown),  strongly  supporting the  conclusion  that 
mitogenic activity and neurite inducing activity reside in the 
same peptide. 
Fig.  3  shows micrographs of PC12  ceils that  have been 
treated with RDGF in the presence of heparin, cells that have 
been treated with NGF, as well as untreated PC12 cells. No 
consistent differences have been observed between neurites 
elicited by NGF and neurites elicited by RDGE Each neurite 
is formed by a growth cone that is attached to the cell body 
by a narrow process.  Although long neurites were induced 
by higher concentrations of RDGF (Fig. 4), the concentra- 
tion of RDGF used in this experiment (10 ng/ml) caused for- 
mation of long neurites only in the presence of heparin. 
Time course  experiments revealed that  there  was a  lag 
period before neurites (short or long) were produced in re- 
sponse to RDGF in either the presence or absence of heparin 
(Fig. 4).  Such a  lag period is also characteristic of the re- 
sponse of these cells to NGF (14, 36).  In contrast,  agents 
such as cholera toxin and adenosine that act by stimulating 
cAMP production are capable of stimulating the formation 
of only short neurites (i.e.,  processes that are <11/2 cell di- 
ameters in  length).  These short cAMP-dependent neurites 
are  formed more  rapidly  (within  8  h)  than  the  processes 
formed in response to NGF (7,  17, 20) or RDGF (within 24 
to  48  h);  but,  unlike  the  NGF-dependent  processes,  the 
cAMP-dependent  processes  do  not  elongate  into  the  long 
neurites (>lV2 cell diameters,  Fig. 4).  Interestingly, cAMP 
and cAMP agonists act synergistically with NGF to stimulate 
the formation of both long and short neurites. This suggests 
that the short, cAMP-dependent neurites may act as precur- 
sors to long neurites (17, 20). Furthermore, although RDGF 
alone stimulated the formation of long neurites at high con- 
centrations (100 ng/ml), more cells produced long neurites 
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Figure 4. Time course of neurite extension by RDGF in the pres- 
ence and absence of heparin.  The time course of the formation of 
both short neurites (---, open symbols) and long neurites (- 
closed symbols) of neurite extension is shown in response to NGF 
(20 ng/ml), (e-o); RDGF (10 ng/ml) plus heparin (10 Ixg/ml), (&- 
zx); and RDGF (100 ng/ml) in the absence of added heparin,  (e-e) 
or cholera toxin (3x10-" M), (,,-[]). A neurite longer than 1  lh cell 
diameters was scored as a long neurite, while a neurite between Vz 
and  ll/z cell diameters  was scored as a short neurite.  Media was 
changed at 48-h intervals. Using this criteria, neither adenosine nor 
cholera toxin effectively stimulates the formation of long neurites 
(16) (J. A. Wagner, unpublished data). Note that in the absence of 
heparin,  100 ng/ml is a subsaturating concentration of RDGF in this 
assay (Fig.  1 A). 
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Figure 5. Antibodies to NGF do not inhibit the extension of neurites 
in response to either purified RDGF or salt extracts of retina. PC12 
cells were incubated with either purified RDGF, a salt extract of  ret- 
ina from which RDGF is prepared (5), or purified beta NGF at con- 
centrations indicated in the figure in the presence or absence of the 
monoclonal antibody (MCI31) that blocks the biological activity of 
NGF (39), and assayed for neurite production at 48 (A) or 96 (B) 
h. The concentrations of NGF and RDGF were chosen so that a 
slightly subsaturating response was obtained. The concentration of 
MCI31 was chosen to be three times that required to block saturating 
concentrations of NGF, and the antibody was preincubated with the 
factors for 5 h before addition to the cells. 
in the presence of heparin even when 10-fold less RDGF (10 
ng/ml) was  used. 
The possibility that RDGF was an alternatively processed 
form of NGF or that the RDGF preparation might have been 
contaminated with  NGF was  eliminated by three criteria. 
First, antibodies specific for NGF blocked neurite extension 
elicited  by  NGF,  but  did  not  prevent  neurite  outgrowth 
elicited by RDGF (Fig. 5 A). Thus, if RDGF is an alterna- 
tively processed form of NGF, it is immunologically distinct. 
Neurite-inducing activity was  also detected in the salt ex- 
tracts of retina  from which  RDGF  was  purified,  and the 
neurite-inducing activity in this extract was also not inhibited 
by antibodies to NGF (Fig. 5 B).  Second, SDS polyacryl- 
amide gels revealed that, if NGF 02,500 D) is present in our 
preparations, it is present at <5% of the level of RDGF (data 
not shown); thus, contamination with NGF is probably not 
an explanation for the activity of RDGF in this assay unless 
an  unusually  active  form of NGF  is  present.  As  a  final 
criterion, NGF can be distinguished  from RDGF because 
NGF did not have any mitogenic activity on either capillary 
EC or 3T3 cells (data not shown).  Thus, NGF and RDGF 
appear to be distinct molecules that control an overlapping 
but nonidentical set of responses. 
Discussion 
These data raise questions about the potential physiological 
role(s) of RDGE RDGF (and the related acidic FGFs) have 
been shown to stimulate a wide variety of EC functions in 
vitro including proliferation (5), migration (19), and protease 
production (29), as well as angiogenesis in vivo (4, 12, 25). 
Thus,  it was  previously suspected that the primary target 
cells for RDGF were of mesenchymal origin. Yet, we show 
in this report that it also has profound effects on PC12 cells, 
which are derived from the neuroectoderm. This suggests 
that it may regulate the differentiation of diverse cell types. 
There is clearly a potential role for a  number of different 
growth factors in regulating neural development (2). Investi- 
gators have noted the parallel nature of blood vessel and neu- 
ral growth during development (34). Our finding that RDGF, 
an angiogenic factor, is also capable of inducing neurite out- 
growth, provides one potential explanation for the apparent 
parallel between the development of the vascular and neural 
networks. 
Although there is no consensus about the mode of action 
of NGF, it appears that NGF regulates both transcriptional 
and nontranscriptional pathways including patterns of pro- 
tein phosphorylation (15, 18). Neurite production in PC12 
cells  is  regulated by at least two distinct pathways.  NGF 
stimulates the production of both long and short neurites af- 
ter a lag of 2 d (36). On the other hand, cAMP can rapidly 
stimulate the formation of short neurites in the absence of 
NGF or act synergistically with NGF to stimulate the forma- 
tion of long neurites (16, 20). The natural regulator of cAMP 
production in PC12 cells is thought to be adenosine (7,  17), 
whereas NGF action is apparently mediated by a distinct sec- 
ond messenger (38). Because neurite formation in response 
to RDGF occurs only after a lag period (Fig. 4) and because 
RDGF stimulates the formation of both long and short neu- 
rites with a time course similar to that of NGF, we suggest 
that RDGF regulates neurite production in a manner similar 
to NGF and distinct from adenosine. 
Previous  studies  have  suggested  that  brain  or pituitary 
FGF,  a cationic heparin-binding growth factor that is also 
an EC mitogen, stimulates neurite outgrowth by PC12 cells. 
The neurite outgrowth stimulated by this basic factor was re- 
ported to be transient and resemble that elicited by cAMP 
rather  than  NGE  Thus  the  effects of RDGF,  an  acidic 
heparin-binding peptide, appear to be qualitatively different 
than the reported effects of basic FGF (37). 
Based  on their biological and biochemical similarities, 
RDGF appeared to be closely related to acidic EC mitogens 
isolated from hypothalamus (22) and brain (8). Antisera pre- 
pared against synthetic peptides of acidic FGF cross react 
with purified RDGF (Sasse and Klagsbrun, personal com- 
munication). Amino acid composition (26) and sequence in- 
formation (1,  8)  suggest identity between these molecules 
though  the  possibility  of tissue-specific  posttranslational 
modifications have not been eliminated. Cationic FGF and 
RDGF (and acidic FGFs) are similar in that they both bind 
strongly to heparin (5,  13, 26, 33). However, the anionic and 
cationic EC mitogens appear to be distinct molecules by four 
criteria: (a) the salt concentration required to elute the fac- 
tors from heparin (5, 13, 22, 26); (b) their isoelectric points 
(5,  13, 22);  (c) their amino acid compositions (8, 26); and 
(d)  their amino  acid  sequences  (1,  8).  We have carefully 
avoided the possibility that RDGF is contaminated with basic 
polypeptides by including, early in our purification scheme, 
a cation exchange column known to bind the basic factors 
(13, 33). 
There is a precedent for the association of growth promot- 
ing activities with basement membrane. A basement mem- 
brane produced by corneal EC has been shown to promote 
neurite extension by PC12 cells (11, 23). A neurite-inducing 
factor was  recently found in conditioned media associated 
with laminin, a major component of  the basement membrane 
(24).  These effects of extracellular matrix on cell function 
could be partially explained by the association of an RDGF- 
like molecule with one of the structural components of the 
matrix. Heparan sulfate and heparin-like molecules are pre- 
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glycans and are accessible to cells of both the vascular and 
neural system (21). The observation that both the mitogenic 
effects and the neurite inducing effect of RDGF are poten- 
tiated by heparin, taken together with the fact that RDGF 
binds with high affinity to heparin, suggests that the associa- 
tion of RDGF with heparin-like components on cell surfaces 
and/or in basement membranes may regulate the presenta- 
tion of RDGF to vascular and neural cells in vivo. 
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Note Added in Proof'. Two recent publications have clearly  demonstrated 
that acidic and basic heparin-binding growth factors are distinct gene prod- 
ucts (Jaye,  M.,  R.  Howk, W.  Burgess, G.  A.  Ricca,  I.-M. Chiu,  M.  W. 
Ravera,  S. J. O'Brien, W.  S.  Modi, T.  Maciag,  and W. N. Drohan,  1986, 
Science  (Wash. DC),  233:541-545;  Abraham,  J.  A.,  A.  Mergia,  J.  L. 
Whang, A. Tumolo, J. Friedman, K. A. Hjerrild, D. Gospodarowicz, and 
J.  C. Fiddes,  1986, Science  (Wash. DC),  233:545-548). 
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